MedPath

TARO-GLICLAZIDE MR

TARO-GLICLAZIDE MR

Approved
DIN Number

02463571

Drug Class

Human

Market Date

Apr 3, 2018

Company
HC

sun pharma canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02463571
AIG Number0119934002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BB09 GLICLAZIDE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification68:20.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

GLICLAZIDEActive
Strength: 30 MG
Monograph: GLICLAZIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.